These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1693988)

  • 1. [Clinical significance of alpha-fetoprotein assay as a tumor marker].
    Endo Y; Iino S; Miyazaki J
    Nihon Rinsho; 1990 Feb; 48 Suppl():949-52. PubMed ID: 1693988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and prognostic importance of the alpha-fetoprotein test in liver cancer and cirrhosis].
    Khazanov AI; Gerasimov GM
    Klin Med (Mosk); 1986 Apr; 64(4):80-5. PubMed ID: 2425125
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What can be the cause of elevated alpha-fetoprotein after hydrocele surgery?].
    Reiner B
    Dtsch Med Wochenschr; 2002 Mar; 127(9):465. PubMed ID: 11870565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker].
    Yamano M
    Nihon Rinsho; 1990 Feb; 48 Suppl():999-1002. PubMed ID: 1693989
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms].
    Cristani A; Borghi A; Cioni G; Vignoli A; Ventura E
    Recenti Prog Med; 1992 May; 83(5):286-7. PubMed ID: 1279760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
    Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
    J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Mao Y; Yang H; Xu H; Lu X; Sang X; Du S; Zhao H; Chen W; Xu Y; Chi T; Yang Z; Cai J; Li H; Chen J; Zhong S; Mohanti SR; Lopez-Soler R; Millis JM; Huang J; Zhang H
    Gut; 2010 Dec; 59(12):1687-93. PubMed ID: 20876776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assay of alpha-fetoprotein by monoclonal antibodies: progress in the diagnosis of hepatocellular carcinoma?].
    Bergman JF; Labadie H; Beaugrand M
    Gastroenterol Clin Biol; 1985 Oct; 9(10):742. PubMed ID: 2415422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
    Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
    Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-foetoprotein: diagnostic significance in liver disease.
    Prakash C; Kumar R; Gupta RR; Lal MM; Mehrotra GC
    Indian J Pathol Microbiol; 1976 Jan; 19(1):49-55. PubMed ID: 61942
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma].
    Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.